Dr. Bailey graduated from the University of Illinois, Chicago College of Medicine in 1984. She works in Lincolnwood, IL and 1 other location and specializes in Internal Medicine. Dr. Bailey is affiliated with Advocate Lutheran General Hospital.
Daniel Schwartz - San Francisco CA, US Keith Duncan - San Francisco CA, US Kathy Bailey - San Francisco CA, US John Kane - San Francisco CA, US Brian Ishida - Walnut Creek CA, US
The present invention addresses the treatment of age-related macular degeneration using regulation of pathogenic mechanisms similar to atherosclerosis. In further specific embodiments, reverse cholesterol transport components, such as transporters and HDL fractions, are utilized as diagnostic and therapeutic targets for age-related macular degeneration. In a specific embodiment, the lipid content of the retinal pigment epithelium, and/or Bruch's membrane is reduced.
Treatments For Age-Related Macular Degeneration (Amd)
Daniel Schwartz - San Francisco CA, US Keith Duncan - San Francisco CA, US Kathy Bailey - San Francisco CA, US John Kane - Hillsborough CA, US Brian Ishida - Walnut Creek CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A61K031/58 A61K031/56 A61K031/203 A61K031/198
US Classification:
514/177000, 514/559000, 514/567000, 514/172000
Abstract:
The present invention addresses the treatment of age-related macular degeneration using regulation of pathogenic mechanisms similar to atherosclerosis. In further specific embodiments, reverse cholesterol transport components, such as transporters and HDL fractions, are utilized as diagnostic and therapeutic targets for age-related macular degeneration. In a specific embodiment, the lipid content of the retinal pigment epithelium, and/or Bruch's membrane is reduced.
Methods To Increase Reverse Cholesterol Transport In The Retinal Pigment Epithelium (Rpe) And Bruch's Membrane (Bm)
Daniel Schwartz - San Francisco CA, US Keith Duncan - San Francisco CA, US Kathy Bailey - San Francisco CA, US John Kane - Hillsborough CA, US Brian Ishida - Walnut Creek CA, US
International Classification:
A61K038/17 A61K031/56
US Classification:
514/002000, 514/171000
Abstract:
The present invention addresses the treatment of age-related macular degeneration using regulation of pathogenic mechanisms similar to atherosclerosis. In further specific embodiments, compositions that increase reverse cholesterol transport are utilized as therapeutic targets for age-related macular degeneration. In a specific embodiment, the lipid content of the retinal pigment epithelium, and/or Bruch's membrane is reduced by delivering Apolipoprotein A1, particularly a mimetic peptide.
Daniel Schwartz - San Francisco CA, US Keith Duncan - San Francisco CA, US Kathy Bailey - San Francisco CA, US John Kane - Hillsborough CA, US Brian Ishida - Walnut Creek CA, US
International Classification:
A61K038/17
US Classification:
514012000
Abstract:
The present invention addresses the treatment of age-related macular degeneration using regulation of pathogenic mechanisms similar to atherosclerosis. In further specific embodiments, compositions that increase reverse cholesterol transport are utilized as therapeutic targets for age-related macular degeneration. In a specific embodiment, the lipid content of the retinal pigment epithelium, and/or Bruch's membrane is reduced by delivering Apolipoprotein A1, particularly a mimetic peptide.
Daniel M. Schwartz - San Francisco CA, US Keith G. Duncan - San Francisco CA, US Kathy R. Bailey - San Francisco CA, US John P. Kane - Hillsborough CA, US Brian Y. Ishida - Walnut Creek CA, US
International Classification:
A61K 9/127 A61K 38/17 A61P 27/02
US Classification:
424450, 514 12
Abstract:
The present invention addresses the treatment of age-related macular degeneration using regulation of pathogenic mechanisms similar to atherosclerosis. In further specific embodiments, compositions that increase reverse cholesterol transport are utilized as therapeutic targets for age-related macular degeneration. In a specific embodiment, the lipid content of the retinal pigment epithelium, and/or Bruch's membrane is reduced by delivering Apolipoprotein A1, particularly a mimetic peptide.
Name / Title
Company / Classification
Phones & Addresses
Kathy Bailey Novi Middle School Teacher
Novi Community School District Elementary/Secondary School